By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Catabasis Pharmaceuticals, Inc. 

161 First Street, Suite 1A

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-349-1971 Fax: 617-273-2637


SEARCH JOBS


Industry
Pharmaceutical






Company News
Catabasis Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering 7/1/2015 11:08:58 AM
Catabasis Pharmaceuticals, Inc. Shares Surge In Nasdaq Debut; Upsizes to Grab $60M in IPO 6/25/2015 10:57:28 AM
Massachusetts Debuts Three Biotech IPOs for $235M As Market Roars 6/22/2015 7:06:04 AM
Catabasis Pharmaceuticals, Inc. Initiates Movedmd, A Phase I/II Trial Of CAT-1004 For The Treatment Of Duchenne Muscular Dystrophy 6/17/2015 9:11:13 AM
Catabasis Pharmaceuticals, Inc. To Present Data For Hypercholesterolemia Product Candidate, CAT-2054, At The National Lipid Association Scientific Sessions 6/9/2015 11:08:29 AM
Catabasis Pharmaceuticals, Inc. Announces Preliminary Phase 1 Data For Hypercholesterolemia Product Candidate CAT-2054 6/4/2015 9:02:09 AM
Catabasis Pharmaceuticals, Inc. Announces Preliminary Phase I Data For Hypercholesterolemia Product Candidate CAT-2054 6/4/2015 8:53:21 AM
Catabasis Pharmaceuticals, Inc. Invited To Present In A Webinar Hosted By Parent Project Muscular Dystrophy 5/8/2015 11:50:11 AM
Catabasis Pharmaceuticals, Inc. Names Ted Hibben SVP, Corporate Development 4/24/2015 7:28:22 AM
Catabasis Pharmaceuticals, Inc. To Present At International Ataxia Research Conference 3/24/2015 12:18:47 PM
123456
//-->